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ABSTRACT 
 
This study investigated the antimicrobial activity of Enterococcus faecium FAIR-E 198 against Bacillus 
cereus, Listeria monocytogenes and Staphylococcus aureus. Using the critical-dilution method, the 
bacteriocin produced by E. faecium FAIR-E 198 inhibited all L. monocytogenes strains evaluated (1,600 to 
19,200 AU mL-1). However, none of the B. cereus and S. aureus strains investigated were inhibited. The 
maximum activity of this bacteriocin (800 AU mL-1) was observed in MRS broth, while the activity in 
milk was 100 AU mL-1. In the co-cultivation test in milk, B. cereus K1-B041 was reduced to below the 
detection limit (1.00 log CFU mL-1) after 48 h.  E. faecium reduced the initial L. monocytogenes Scott A 
population by 1 log CFU mL-1 after 3 h at 35ºC. However, the pathogen regained growth, reaching 3.68 log 
CFU mL-1 after 48 h. E. faecium did not influence the growth of S. aureus ATCC 27154 during the 48 h of 
co-cultivation. Therefore, it can be concluded that the effectiveness of the antimicrobial activity of E. 
faecium FAIR-E 198 is strictly related to the species and strain of the target microorganism and to the 
culture medium. 
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INTRODUCTION 
 
The potential risk posed by the presence of pathogens in 
dairy products is a constant concern in the field of food safety 
for both the food processing industry and government 
authorities. A number of foodborne disease outbreaks have 
been associated with these products (19). Although most of 
these outbreaks were closely related with the consumption of 
dairy products made from raw milk (5, 7), post-processing 
contamination must be taken into account as an important risk 
factor in the manufacture of such products. 
Reduction of pH due to the production of organic acids, 
particularly lactic acid, by fermentation of naturally occurring 
carbohydrates in foods is responsible for the main antagonistic 
effect against a series of different microorganisms. However, 
nutrient competition and the formation of other compounds 
with inhibitory activity (hydrogen peroxide, diacetyl and 
bacteriocin) are important antimicrobial functions of lactic-acid 
bacteria (17). Bacteriocins are peptides or proteins with 
antimicrobial activity that are synthesized by the ribosomes of 
lactic-acid bacteria. 
Numerous reports describing bacteriocin activity in  
 
*Corresponding Author. Mailing address: Instituto de Tecnologia de Alimentos, Av. Brasil, 2880, 13070-178, Campinas, SP, Brasil.; Tel: 19 3743-1815 Fax: 
19 3743-1822.; E-mail: mnascimento@ital.sp.gov.br  
 75 
Antimicrobial activity of E. faecium 
 
 
 
 
Enterococcus species have been published in recent years. 
Most of the bacteriocin producer strains have been isolated 
from dairy products (10, 23). Some of these species, 
particularly Enterococcus faecium, provide probiotic and 
technological benefits, including the ability to grow at 
refrigeration temperatures over a wide pH range and in the 
presence of up to 6.5% NaCl (4, 20), in addition to improving 
cheese flavor. However, there is controversy in literature 
regarding its pathogenic potential. Giraffa et al. (14) state that, 
like other lactic-acid bacteria, enterococci species may 
occasionally be involved in clinical infections, but that in spite 
of this, many strains are considered safe for use in foods. An 
example of such a strain is E. faecium K770, which was 
approved in 1996 in the United Kingdom for use in cultured 
dairy products (13).  
E. faecium FAIR-E 198, a strain isolated from Greek Feta 
cheese, is a bacteriocin producer (26) and was found to be a 
poor acidifier in milk (25). In general, enterocins have selective 
antimicrobial activity against the genus Listeria and are not 
effective against lactic acid bacteria (16, 20). However, some 
authors observed activity of enterocins against other Gram-
positive pathogens like Bacillus cereus (9) and Staphylococcus 
aureus (2). This suggests that bacteriocinogenic entrococci 
strains or their enterocins may be used to enhance the 
microbiological safety of fermented dairy products. 
The aim of this study was to verify the viability of using E. 
faecium FAIR-E 198 as an adjunct culture in dairy products to 
control gram-positive pathogens. To this end,  the growth and 
production of the bacteriocin by E. faecium FAIR-E 198 in 
MRS broth and milk was evaluated and the spectrum of 
antimicrobial activity was determined. In addition, the behavior 
of Bacillus cereus, Listeria monocytogenes and Staphylococcus 
aureus during co-cultivation with this bacteriocins-producing 
bacterium in milk were analyzed. 
 
MATERIALS AND METHODS 
 
Bacterial strains and media 
Bacterioci- producing Enterococcus faecium FAIR-E 198 
(strain ACA-DC 1618, Laboratory of Dairy Research, 
Agricultural University of Athens, Greece) was isolated from 
Feta cheese (26). This strain was stored at 4 ºC in de Man 
Rogosa Sharpe (MRS) broth (Difco, Becton Dickinson, Sparks, 
MD). The pathogenic bacteria were purchased from the Faculty 
of Food Engineering, Campinas State University (Campinas, 
Brazil) and the Bacterial Collection of the Oswaldo Cruz 
Foundation (Rio de Janeiro, Brazil). Listeria monocytogenes 
strains were maintained in trypticase soy agar supplemented 
with 0.6% yeast extract (TSA-YE, Difco), Staphylococcus 
aureus in brain-heart infusion agar (BHI, Difco) and Bacillus 
cereus in trypticase soy agar (TSA, Difco). Before being used 
in the tests, the strains were grown in media and at temperature 
indicated for each culture. 
 
Pathogenicity tests 
Gelatinase production was determined in nutrient gelatin 
agar (Difco) after incubation at 37ºC for up to seven days. A 
positive reaction was indicated by liquefaction of the medium 
after incubation at 21 ºC for two hours. Thermonuclease 
activity was assessed using Bacto-DNAse Test agar (Difco) 
supplemented with 0.83% toluidine blue (Sigma-Aldrich, Saint 
Louis, MO.). Each well made in the agar was filled with 
aliquots of 50 µL of the strain that had been previously heated 
for 15 min at 100 ºC. The presence of a pink coloration around 
the wells after incubation for 24 h at 37 ºC was indicative of 
thermonuclease activity (3). 
 
Determination of antimicrobial spectrum 
The sensitivity of 25 B. cereus strains, ten L. 
monocytogenes strains and five S. aureus strains to the 
bacteriocin produced by E. faecium FAIR-E 198 were 
evaluated using an adapted critical-dilution method (18). 
Culture plates were prepared with TSB soft agar (0.9% agar) 
and TSB-YE soft agar previously inoculated with 1% (0.2 mL) 
of the B. cereus, S. aureus and L. monocytogenes (106-107 CFU 
mL-1) cultures, respectively. The overnight bacteriocinogenic 
cultures were centrifuged at 7,500 × g for 15 min at 4 ºC 
(Beckman J2-21 Centrifuge, Palo Alto, Calif.). The 
supernatants were adjusted to pH 6.5 and sterilized by filtration 
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through a 0.22 µm membrane (Millipore, Carrigtwohill, 
Ireland). Then, 10 µL of serial two-fold dilutions of cell-free 
culture supernatants in 10 mM sodium phosphate buffer, pH 
7.0, were spotted onto plates containing the pathogens. The 
plates were incubated for 24 h at 35 ºC. The bacteriocin 
activity was expressed in arbitrary units per milliliter (AU mL-
1), corresponding to the reciprocal of the highest dilution 
causing a clear inhibition zone on the indicator strain and was 
multiplied by a factor of 100. 
 
Effect of culture media on bacteriocin production 
The cell suspensions, containing approximately 105–106 
CFU mL-1 of the bacteriocinogenic culture, were inoculated 
into MRS broth and into 10% reconstituted skim milk powder 
(RSM). The inoculated samples were incubated at 37 ºC for 48 
h. Then, samples of the cultures were collected at 3 h intervals 
during the first 12 h and after 24 and 48 h of incubation. 
Microbial counts were determined by plating onto KF 
Streptococcus agar (Difco) and incubated at 37 ºC for 48 h. 
The pH was determined by a pH-meter (Hanna Instruments HI 
9110, Singapore). Bacteriocin production was determined by 
the critical-dilution method using L. monocytogenes Scott A as 
an indicator microorganism. 
 
Co-cultivation of gram-positive pathogens and FAIR-E 198 
in milk 
The bacteriocin-producing culture (106–107 CFU mL-1) 
was cultivated separately with B. cereus K1-B041, L. 
monocytogenes Scott A and S. aureus ATCC 27154 
(approximately 102 CFU mL-1) in RSM and incubated at 35 ºC 
for 48 h (6, 24). Milk samples individually inoculated with 
each of the species investigated were used as control. Samples 
were collected after 0, 3, 6, 9, 12, 24 and 48 h of incubation. E. 
faecium counts were performed on KF Streptococcus plates 
after incubation at 37 ºC for 48 h. Modified Oxford agar 
(Difco) was used for L. monocytogenes, Baird-Parker agar 
(Difco) for S. aureus, both of which were incubated at 35 ºC 
for 48 h, and Mannitol-Egg-yolk-Polymyxin agar (MYP, 
Difco) was used for B. cereus, with incubation at 30 ºC for 24 
h. The identity of the colonies recovered in the selective media 
was confirmed using biochemical tests (12). Immediately upon 
collection, the pH of each sample was measured by a pH meter. 
The bacteriocin activity against the three pathogens 
investigated was determined by the critical-dilution method. 
 
Statistical analysis 
Analysis of variance (ANOVA) and the Tukey test at the 
5% level of significance were used to compare means among 
and within experimental groups. 
 
RESULTS AND DISCUSSION 
 
Pathogenicity potential 
Before being used in food technology, all enterococci 
strains must have their pathogenicity factors carefully 
analyzed. The results of the pathogenicity tests performed 
showed that E. faecium FAIR-E 198 was negative for 
gelatinase and thermonuclease activities. In previous studies, 
this strain was non-hemolytic when tested on sheep or human 
blood, and exhibited no resistance to vancomycin and 
teicoplanin (26, 28). All the above characteristics are indicative 
of the absence of pathogenicity. However, more tests are 
necessary to confirm this, such as the identification of 
virulence genes.  
 
Spectrum of activity 
The use of bacteriocins or bacteriocinogenic cultures in 
biopreservation of foods may be considered as an additional 
tool to enhance the microbiological safety and reduce the risk 
of the development of spoilage microorganisms. In this study, 
the enterocin produced by E. faecium FAIR-E 198, like most 
Class IIa bacteriocins, showed activity predominantly against 
L. monocytogenes, inhibiting all ten strains evaluated (1,600 to 
19,200 AU mL-1) by the critical-dilution method. The differing 
susceptibility observed in L. monocytogenes strains and the 
absence of sensitivity shown by all the 25 B. cereus and five S. 
aureus strains to the bacteriocin (Table 1) can be explained by 
natural variation in susceptibility and the ability to develop 
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resistance to bacteriocins. Ennahar and Deschamps (11) 
observed that enterocin A produced by E. faecium EFM01 
inhibited 13 out of a total of 14 L. monocytogenes strains, 
while none of 7 S. aureus strains investigated were inhibited by 
this bacteriocin. On the other hand, Ammor et al. (2) reported 
antimicrobial activity of enterocins produced by E. faecium 
against S. aureus strains. 
 
 
Table 1. Antimicrobial spectrum of the bacteriocin produced by E. faecium FAIR-E 198.  
Pathogen specie Strain 
Inhibitory activity 
(AU/mL) 
Listeria monocytogenes IOCa 1551, SCOTT A 1.600 
 IOC 1324, ATCCb19111, ATCC 7644 3.200 
 IOC 1630 4.800 
 IOC 1359, IOC 1898  6.400 
 ATCC 19115 12.800 
 IOC 1527 19.200 
   
Staphylococcus aureus  ATCC 8095, ATCC 13565, ATCC 19095, ATCC 
27154, ATCC 27664 
NDd 
   
Bacillus cereus  ATCC 14579, K1c- B010, K1-B016, K1-B020, K1-
B021, K1-B025, K1-B037, K1-B040, K1-041, K1-
B043, K1-B048, K1-B050, K1-B069, K1-B070, K1-
B071, K1-B072, K1-B074, K1-B097, K1-B098, K1-
B128, K1-B129, K1-B130, K1-B131, K1-B132, K1-
B146 
ND 
a
 IOC: Instituto Oswaldo Cruz (Rio de Janeiro, BR),  
b ATCC: American Type Culture Collection (Rockville, USA),  
c K1: Faculdade de Engenharia de Alimentos, Universidade Estadual de Campinas (Campinas, BR),  
d Not detected. 
 
 
Bacteriocin production in MRS broth and milk 
The production of bacteriocins by E. faecium FAIR-E 198 
was influenced by the culture medium. In MRS broth, this 
strain reached a maximum population level of 7.90 log CFU 
mL-1 after 12 h, remained stable up to 24 h of incubation, but 
decreased by 1 log CFU mL-1 after 48 h. Acidification of the 
MRS broth began after 6 h, resulting in a pH of 3.72 after 48 h. 
The bacteriocin activity, measured using L. monocytogenes 
Scott A as an indicator microorganism, was first detected after 
9 h of incubation (100 AU mL-1), during the log-phase, and 
reached a maximum of 800 AU mL-1 after 24 h, during the 
stationary phase (Fig. 1A). However, several authors have 
reported maximum enterocin activity during or at the end of the 
exponential growth phase (1, 26). The pronounced decrease in 
bacteriocin activity (87.5%) observed after 24 h may be related 
to protein aggregation, proteolytic inactivation or adsorption of 
the bacteriocin onto the producer cell surface (8).  
In milk, E. faecium FAIR-E 198 reached a count of 8.10 
log CFU mL-1 after 24 h, followed by a drop of 0.90 log CFU 
mL-1 after 48 h. During bacterial growth, the pH of the milk 
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decreased from 6.45 to 5.08. Bacteriocin activity was observed 
only after 6 h (100 AU mL-1) and was no longer detected up 
until the end of the incubation period (Fig. 1B). 
Sarantinopoulos et al. (26) evaluated this same strain and 
obtained a similar result using milk supplemented with casein 
hydrolysate (1.4%). According to Moreno et al. (20), the 
enterococci showed low proteolytic activity and consequently 
slower metabolism. This fact might be the reason why 
bacteriocin production in milk is lower than in broth. Another 
explanation for the low enterocin activity in milk may lie in 
interactions of this substance with milk components, such as fat 
and casein (21). 
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Figure 1. Growth of Enterococcus faecium FAIR-E 198 in MRS broth 
(A) and skim milk (B). Growth (), bacteriocin activity against L. 
monocytogenes Scott A () and pH (). 
Co-cultivation with Gram-positive pathogens 
The initial counts (2 log CFU mL-1) of the pathogens used 
in these tests were based on the contamination level normally 
found in dairy products. B. cereus K1-B041 in the control 
sample reached a count of 8.37 log CFU mL-1 after a 48-h 
incubation (Fig. 2A). During the first 24 h of co-cultivation 
with the bacteriocinogenic culture, no significant reduction 
(<0.70 log CFU mL-1) was observed in the B. cereus 
population. However, after 48 h, this pathogen population was 
reduced to below the detection limit (<1.00 log CFU mL-1). 
The bacteriocinogenic culture reached viable cell counts of 
8.13 log CFU mL-1 after 48 h. No bacteriocin activity against B. 
cereus was detected during 48 h of incubation. A significant 
difference (P≤0.05) was observed between the pH values of the 
control sample and the co-cultivation sample after 9 h. 
Therefore, the significant reduction of the B. cereus K1-B04 
population observed after 48 h of co-culture with E. faecium 
FAIR-E 198 may be attributed to the reduction of the pH to 
lower than 4.4. Wong and Chen (29) reported that the 
development of B. cereus is impaired when the pH of the 
culture medium is lower than 5. According to Rossland et al. 
(24), a rapid decrease of the pH at the beginning of the 
logarithmic phase would be strongly related to pathogen 
inhibition.  
The effect of the bacteriocin produced by E. faecium 
FAIR-E 198 on the cell viability of L. monocytogenes Scott A 
during growth in milk is shown in Figure 2B. The control 
sample, initially inoculated with 2.63 log CFU mL-1 of L. 
monocytogenes, reached a population of 7.26 log CFU mL-1 
after 48 h. The bactericidal activity of E. faecium reduced the 
L. monocytogenes Scott A count from 2.19 to 1.15 log CFU 
mL-1 during the first 3 h of incubation, after which the 
remaining bacterial cells regained growth, attaining 3.68 log 
CFU mL-1 after 48 h of incubation. During the same period, the 
population of the bacteriocinogenic culture increased from 6.00 
to 7.32 log CFU mL-1. Bacteriocin activity (100 AU mL-1) 
produced by this culture was detected only in the sample 
analyzed after a 6-h incubation. The pH values of the co-
cultivated E. faecium sample were lower than the pH values of 
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the control sample containing only L. monocytogenes over the 
entire incubation period. After 48 h, the pH of the co-cultivated 
sample was 5.30, while the control sample exhibited a pH 
value of 6.10. The reductions of L. monocytogenes obtained in 
this study were greater than those reported by Elotmani et al. 
(9), using another E. faecium strain. The initial bactericidal 
effect of E. faecium FAIR-E 198 against L. monocytogenes 
Scott A and the subsequent growth recovery of the pathogen 
may be related to the production of amounts of bacteriocin 
insufficient to inhibit all the cells of the target microorganism. 
A similar phenomenon has previously been commented upon 
by Muriana (22) with respect to other bacteriocinogenic 
cultures. 
In relation to S. aureus ATCC 27154, the control sample 
initially inoculated with 2.79 log CFU mL-1 exhibited a 
population of 8.80 log CFU mL-1 after 24 h (Fig. 2C). This was 
followed by a decline phase, and after 48 h of incubation, the S. 
aureus reached a viable cell count of 7.10 log CFU mL-1. The 
count of the bacteriocinogenic culture increased by 2.00 log 
CFU mL-1 after 48 h. Nonetheless, no bacteriocin activity of 
any kind against S. aureus was observed throughout the 
incubation period. No significant difference (P≥0.05) was 
found between the pH of the S. aureus control sample and the 
co-cultivation sample. E. faecium FAIR-E 198 did not show 
bacteriocin activity or any other significant inhibitory effect 
(P≥0.05) against S. aureus ATCC 27154 during the 48 h 
incubation. According to Sutra et al. (27) Staphylococcus 
possess the ability to form a viscous or gelatinous 
polysaccharide capsule that prevents the penetration of 
antimicrobial substances into the bacterial cells. However, 
Lauková et al. (15) studied the effect of enterocin CCM 4231 
on the growth of S. aureus in milk and observed a reduction in 
the number of viable cells of the pathogen from 1010 CFU mL-1 
to 102 CFU mL-1 after a 24-h incubation. 
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Figure 2. Growth evolution of co-culture of (A) B. cereus 
K1-B041, (B) L. monocytogenes Scott A or (C) S. aureus 
ATCC 27154 with E. faecium FAIR-E 198 in skim milk 
during 48 h at 35 ºC. E. faecium FAIR-E 198 counts () 
in co-cultivation. Pathogen counts in culture control () 
or in co-cultivation with E. faecium FAIR-E 198 (∆∆). pH 
of the media in co-cultivation (----) and in culture control 
of pathogen (----).  
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CONCLUSION 
 
The effectiveness of the antimicrobial activity of E. 
faecium FAIR-E 198 is strictly related to the species and strain 
of the target microorganism and to the culture medium. This 
lactic-acid bacterium shows interesting characteristics for use 
as an additional safety provision within the context of hurdle 
technologies to interact with other barriers for the control of 
foodborne Gram-positive pathogens in dairy products. 
However, to this end, more studies on virulence factors and 
antibiotic resistance are necessary.  
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